This databook provides key data and information on the Cough and Cold Preparations Market in Pakistan (OTC Healthcare). This report is a comprehensive resource for market, category and segment level data including value, volume, distribution share and company & brand share. This report also provides expenditure and consumption data for the historic and forecast periods.
Scope
- Market,category and segment level information on value, volume, and expenditure & consumption, with historic (2003-2008) and forecast (2009-2013) data
- Category level company and brand share as well as distribution share information for 2007 and 2008
The cough and cold preparations category was valued at PKR5,237.6m ($74.4m) in 2009, representing a CAGR of 6.8% since 2004.
By the end of 2014, the cough and cold preparations category will be worth PKR6,763.7m ($96.1m), with an expected CAGR of 5.2% between 2009 and 2014.
The cough and cold preparations market was led by mixtures (representing 39.5% of the total value) followed by tablets and lozenges, with a 28% and 11.8% market share, respectively. Topical remedies and inhalers constitute the remaining segments with a 10.8% and 9.9% market share, respectively.
Johnson & Johnson is the market leader with a 41.5% share of the market.
Reasons to Purchase
- Develop business strategies by understanding the quantitative trends within the Cough and Cold Preparations Market in Pakistan (OTC Healthcare)
- Design effective marketing and sales strategies by identifying key market categories and segments
- Identify key players within the market to plan lucrative M&A, partnerships and agreements